PCMTD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.877000E-01
Normal-vs-Stage2
9.901900E-02
Normal-vs-Stage3
1.301910E-02
Normal-vs-Stage4
4.686200E-01
Stage1-vs-Stage2
9.478400E-02
Stage1-vs-Stage3
1.303190E-03
Stage1-vs-Stage4
6.115400E-01
Stage2-vs-Stage3
8.525500E-02
Stage2-vs-Stage4
3.546200E-01
Stage3-vs-Stage4
2.044500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.029000E-01
Normal-vs-AfricanAmerican
2.188800E-01
Normal-vs-Asian
1.592770E-01
Caucasian-vs-AfricanAmerican
9.932000E-01
Caucasian-vs-Asian
5.410800E-01
AfricanAmerican-vs-Asian
6.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.314000E-01
Normal-vs-Female
2.094800E-01
Male-vs-Female
9.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.404200E-01
Normal-vs-Age(41-60Yrs)
4.731000E-01
Normal-vs-Age(61-80Yrs)
2.336800E-01
Normal-vs-Age(81-100Yrs)
5.906000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.957600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.002400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.093200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.903800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.018000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.085900E-02
Normal-vs-Daily Drinker
3.441600E-01
Normal-vs-Weekly Drinker
8.255700E-02
Normal-vs-Occasional Drinker
6.675000E-01
Normal-vs-Social Drinker
4.893200E-01
Non Drinker-vs-Daily Drinker
5.002400E-01
Non Drinker-vs-Weekly Drinker
9.642600E-01
Non Drinker-vs-Occasional Drinker
7.166100E-02
Non Drinker-vs-Social Drinker
4.398800E-01
Daily Drinker-vs-Weekly Drinker
6.103400E-01
Daily Drinker-vs-Occasional Drinker
3.193400E-01
Daily Drinker-vs-Social Drinker
8.083000E-01
Weekly Drinker-vs-Occasional Drinker
1.278200E-01
Weekly Drinker-vs-Social Drinker
4.865800E-01
Occasional Drinker-vs-Social Drinker
5.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.810800E-01
Normal-vs-Grade 2
3.452200E-02
Normal-vs-Grade 3
5.333500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.977440E-01
Grade 1-vs-Grade 3
1.908600E-01
Grade 1-vs-Grade 4
2.810800E-01
Grade 2-vs-Grade 3
8.881800E-01
Grade 2-vs-Grade 4
3.452200E-02
Grade 3-vs-Grade 4
5.333500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.480100E-02
Normal-vs-NonDiabetic
3.898200E-01
Diabetic-vs-NonDiabetic
5.424000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.237900E-02
Normal-vs-NoPancreatitis
3.078800E-01
Pancreatitis-vs-NoPancreatitis
2.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.708000E-01
Normal-vs-N1
9.450000E-02
N0-vs-N1
2.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.202000E-01
Normal-vs-TP53-NonMutant
7.435200E-01
TP53-Mutant-vs-TP53-NonMutant
3.357700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
